The Independent’s journalism is supported by our readers. When you purchase through links on our site, we may earn commission.

Morning after pill sold online for £4.99 sparks concerns

Has it become too accessible?

Olivia Petter
Thursday 14 September 2017 16:25
Comments

When online pharmacy Chemist 4 U revealed that they would be selling the morning after pill to women for just £4.99 per pack, the news polarised opinions.

Initially, the UK website was praised for its progressive move – being the first to make the pill available to buy online at such an affordable price tag.

However, campaigners on reproductive ethics have been quick to condemn the initiative, explaining that the accessibility presents the morning-after pill as custom contraception, when doctors advise only taking it in emergencies.

The online retailer is offering customers the opportunity to bulk buy a generic version of Levonelle, a well-known form of the morning-after pill.

Women will be able to buy as many as three packs of the pill in six months – whereas it has previously only ever been sold individually, after in-store consultations at high street pharmacies.

In some cases, the pill can be obtained for free on the NHS and at some sexual health clinics.

Now all it takes is an online form which is reviewed by a Chemist 4 U medic before distributing the drug at what Josephine Quintavelle, from Comment on Reproductive Ethics, calls “pocket money prices,” reports The Telegraph.

She explained that the low price tag raises moral concerns as it misleadingly normalises the act of taking the morning after pill so that it becomes all-too-casual a process when in fact, taking the pill, particularly more than a few times, comes with a slew of risks.

Experts have always strongly advised that women shouldn’t take it on a regular basis, though some have argued that Chemist 4 U’s “advanced supply” initiative inadvertently advocates doing so.

"They sell the product as an 'advance' purchase, ensuring a customer has a product on their shelf in case of emergencies," a spokesperson for Chemist 4 U told The Independent.

“We always advise women in an emergency situation, to go to their nearest pharmacy that day, rather than waiting a day to receive it from an online pharmacy," explained Chemist 4 U's managing director, Shamir Patel.

"However our belief is, an advanced supply from us avoids the panic in the unlikely event of barrier method failure. We advise all patients that EHC should not be used as a regular contraceptive method,” he said.

The initiative comes after Boots and Superdrug drastically reduced prices of the pill sold in store – with Superdrug’s dropping from £27 to £13.49. Tesco also sell it for £13.50.

However, the price reductions were not without controversy either. Initially, after the British Pregnancy Advisory Service urged high street retailers to drop prices of the morning after pill, Boots refused, claiming that it would encourage women to “abuse” it and that it might promote “inappropriate use.”

Alas, Boots ultimately retracted their claims and reduced the price of the pill from £26 to £15.99.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in